Cytiva, a global life sciences leader, has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines. Fully compliant and offering automated instrumentation, the NanoAssemblr commercial formula...

Entos Pharmaceuticals partners with Precision Nanosystems to enable highly scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine and other genetic nanomedicines

Vancouver BC, March 24, 2020  Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI’s NanoAssemblr™ technology and co...

Precision NanoSystems (PNI) is pleased to introduce our newest member of the Nanoassemblr® Platform: the Ignite™ available October 15, 2019.

“The Ignite embodies everything that made the NanoAssemblr family of instruments the go-to platform for developin...